Cargando…

Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries

BACKGROUND: Tafenoquine is a long half-life primaquine analog being developed for malaria prophylaxis. The US Army recently performed a unified analysis of efficacy in preparation for a regulatory submission, utilizing legacy data from three placebo-controlled studies conducted in the late 1990s and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dow, Geoffrey S., Liu, Jun, Lin, Gina, Hetzell, Brian, Thieling, Sarah, McCarthy, William F., Tang, Douglas, Smith, Bryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661991/ https://www.ncbi.nlm.nih.gov/pubmed/26610844 http://dx.doi.org/10.1186/s12936-015-0991-x

Ejemplares similares

A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area
por: Dow, Geoffrey S, et al.
Publicado: (2014)

The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg)
por: Dow, Geoffrey, et al.
Publicado: (2017)

Tafenoquine succinate for malaria prevention
Publicado: (2019)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
por: Commons, Robert J, et al.
Publicado: (2020)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
por: Birrell, Geoffrey W., et al.
Publicado: (2022)

521. A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease
por: Dow, Geoffrey
Publicado: (2023)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
por: Baird, J Kevin
Publicado: (2018)

Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections
por: Li, Qigui, et al.
Publicado: (2014)

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
por: Marcsisin, Sean R, et al.
Publicado: (2014)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
por: Lacerda, M.V.G., et al.
Publicado: (2019)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
por: St Jean, Pamela L., et al.
Publicado: (2020)

Tafenoquine for Plasmodium vivax malaria: Concerns regarding efficacy & safety
por: Sharma, Jatin, et al.
Publicado: (2021)

A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease
por: Dow, G.-S., et al.
Publicado: (2022)

Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas
por: Greenwood, Brian
Publicado: (2010)

Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries
por: Kovacs, Stephanie D., et al.
Publicado: (2017)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
por: Baird, J Kevin
Publicado: (2021)

Tafenoquine: a toxicity overview
por: Chu, Cindy S., et al.
Publicado: (2021)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
por: Haston, Julia C., et al.
Publicado: (2019)

Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
por: Suh, Jiyeon, et al.
Publicado: (2022)

Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines
por: Berman, Jonathan, et al.
Publicado: (2018)

Opium as a Prophylactic of Malarious Fevers
Publicado: (1874)

Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers
por: Ackert, Jessica, et al.
Publicado: (2019)

Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study
por: Sutanto, Inge, et al.
Publicado: (2023)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
por: Ebstie, Yehenew A, et al.
Publicado: (2016)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
por: Markus, Miles B
Publicado: (2021)

Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum
por: Barber, Bridget E, et al.
Publicado: (2023)

Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria
por: Mayence, Annie, et al.
Publicado: (2019)

The Factors Determining Malarial Endemicity
Publicado: (1902)

Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)
por: Dow, Geoffrey S, et al.
Publicado: (2011)

Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial
por: Thakkar, Nilay, et al.
Publicado: (2018)

An Efficient and Sustainable Synthesis of the Antimalarial Drug Tafenoquine
por: Kavthe, Rahul D., et al.
Publicado: (2022)

Malarial Retinopathy: the Summary on Contemporaneous Hypothesis
por: Wiwanitkit, Viroj
Publicado: (2012)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
por: Watson, James A, et al.
Publicado: (2022)

Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set
por: Sharma, Raman, et al.
Publicado: (2023)

Serological and Molecular Study of the Duffy Blood Group among Malarial Endemic Region Residents in Brazil
por: Langhi, Dante, et al.
Publicado: (2022)

Malaria and Malarial Diseases
Publicado: (1884)

Cannot write session to /tmp/vufind_sessions/sess_6ffodvcoeki3s73hguouemvp35